This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74457764
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunetu de 1956 wetenschappelijk artikel наукова стаття, опублікована в липні 1956 im Juli 1956 veröffentlichter wissenschaftlicher Artikel 1956 թվականի հուլիսի 1-ին հրատարակված գիտական հոդված scientific article published on 01 July 1956
p:P577
wds:Q74457764-D95458E4-5217-4759-BFF0-1ACBEB2B5604
wdt:P577
1956-07-01T00:00:00Z
p:P2093
wds:Q74457764-966A44DD-BFB6-41E0-B021-5CB3A045E63C
wdt:P2093
F J AYD
rdfs:label
The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management
skos:prefLabel
The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management
schema:name
The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management
p:P1476
wds:Q74457764-682CBDF4-6F9B-4221-AC84-F48109472956
wdt:P1476
The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management
p:P304
wds:Q74457764-DCFB8BA8-A9C1-458B-8C86-F61C6609D1D7
wdt:P304
84-87
p:P31
wds:Q74457764-D441D067-40DD-4AAA-95D2-4A796577BC1C
wdt:P31
wd:Q13442814
p:P921
wds:Q74457764-1505E97E-9454-4F10-8F5B-462EC8EE5172
wdt:P921
wd:Q407972
p:P698
wds:Q74457764-D40677AB-BA2F-4F91-838E-A738E0DD7923
wdtn:P698
n11:13416925
wdt:P698
13416925
p:P1433
wds:Q74457764-CA96E31F-9A8F-4006-95B7-46724BA76D6E
wdt:P1433
wd:Q598644
p:P433
wds:Q74457764-27CE63C8-247F-4B38-AD68-B746DF35D4E7
p:P478
wds:Q74457764-10DD471F-DD33-473A-AB5A-184E880A289A
wdt:P433
1
wdt:P478
124
p:P356
wds:Q74457764-15063E88-BCCB-449C-A9A1-638F271344E0
wdtn:P356
n10:00005053-195607000-00013
wdt:P356
10.1097/00005053-195607000-00013